More patients in the 1500 mg group than in the placebo group were monthly responders for at least 3 months (47.1% vs 28.0%; P = .0432).There was no statistically significant difference between the ...

In the study, "Mesalamine Granules 1500 mg Once daily for 12 Weeks Provides Adequate Relief of IBS Symptoms in Irritable Bowel Syndrome with Diarrhea: Results from a Phase 2 Trial," 148 patients ...

One study presented today found that mesalamine granules, an anti-inflammatory drug used to treat ulcerative colitis, improved abdominal pain and stool consistency in diarrhea-predominant IBS.

Research unveiled today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas suggests a possible overlap of symptoms of two prevalent GI disorders ...

The results of two studies suggest a possible link between GI tract inflammation and irritable bowel syndrome symptoms, according to a news release (pdf). The studies, which were presented at the ...

Mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. Patients with IBD are at ...

Mesalamine use among patients with inflammatory bowel disease was associated with a decrease in incidence of colorectal cancer when comparing cases and controls. Patients with IBD are at ...

Adjunctive therapy with curcumin was found to provide a greater clinical benefit than placebo in patients with ulcerative colitis (UC) being treated with mesalamine, according to the findings of a ...

October 17, 2007 (Philadelphia) — Mesalamine use in patients with inflammatory bowel disease (IBD) is associated with a significant risk reduction in colorectal cancer, a single-center study ...

SAN ANTONIO — Older patients with Crohn’s disease were less likely to receive biologic agents and more than twice as likely to receive mesalamine compared with younger patients, according to ...

Epidermal growth factor (EGF) is a potent mitogenic peptide produced by salivary glands. We examined whether EGF enemas are an effective treatment for active left-sided ulcerative colitis and ulcer ...

Mesalamine Did Not Prevent Recurrent Diverticulitis in Phase 3 Controlled Trials – Gastroenterology Currently there is no treatment for the prevention of diverticulitis recurrence, although ...